Full-Time

Executive Director

Regulatory Liaison

Confirmed live in the last 24 hours

Merck

Merck

10,001+ employees

Develops medicines and vaccines for health issues

Compensation Overview

$227.3k - $357.9k/yr

+ Bonus + Long Term Incentive

Senior, Expert

Boston, MA, USA + 3 more

More locations: North Bethesda, MD, USA | North Wales, PA, USA | Linden, NJ, USA

Hybrid work model requiring three days in the office per week.

Category
Risk & Compliance
Legal & Compliance
Requirements
  • B.S. or M.S. with a minimum of 12 years relevant drug development experience, a majority of which was in Regulatory OR M.D. or PhD or PharmD with a minimum of 7 years relevant drug development experience preferably with 5 years in Regulatory.
  • Companion Diagnostics/In Vitro Diagnostics regulatory experience required.
  • Demonstrated scientific knowledge, writing ability, effective communication and thorough familiarity with worldwide regulatory agencies.
  • Outstanding interpersonal, communication and negotiation skills.
  • Demonstrated leadership attributes; experienced at building and leading high performing teams or projects; exemplifies corporate and ethical integrity; drives success consistent with company values and priorities.
Responsibilities
  • Effectively communicate to (and manage) multiple senior stakeholders in our Research and Development (R&D) Division and Global Human Health (GHH) to bring an awareness of the product/program risks.
  • Collaborate and work effectively across boundaries to enable the timely (proactive) resolution.
  • Demonstrate leadership capabilities to drive an effective conversation at senior levels.
  • Oversight and management of regulatory strategists including review of regulatory strategy for respective products as needed.
  • Lead complex programs or components thereof of significant value to the company.
  • Apply high-level scientific judgment in a variety of highly complex and unprecedented situations.
  • Review and approve regulatory submissions.
  • Review and approve communication materials to be used external to our Company such as press releases for accuracy and consistency of message.
  • Review and approve background packages to ensure clarity and comprehensive presentation of issues.
  • Review labeling and manage label negotiations with agencies worldwide as appropriate to obtain and maintain optimal labeling consistent with the company core data sheet.
  • Participate in regulatory due diligence activities for licensing candidate review.
  • Manage assignments for their regulatory liaisons, including resourcing for project assignments.
  • Provide technical and professional leadership to staff and conduct all appropriate HR activities such as managing performance, development planning; staffing and related people-management responsibilities for regulatory liaisons within areas of responsibility.
  • Develop relationship with external stakeholders (industry and regulators) to understand the current landscape and influence internally to implement rigorous, innovative and science-based approaches to our development and submissions.
  • Represent our Company as needed at external initiatives notably with regulatory authorities.
Desired Qualifications
  • Preferred: M.D. or PhD in biological science, chemistry or related discipline.
  • Prior people management experience.
  • Regulatory affairs experience with digital health products.

Merck develops medicines and vaccines to address significant health challenges such as cardiovascular disease, diabetes, and cancer. The company conducts extensive research and development to create new treatments, focusing on the pharmaceutical and biotechnology sectors. Merck generates revenue through the sale of prescription medications, vaccines, and animal health products. A key aspect of Merck's approach is its commitment to patient assistance programs, which provide free medicines and vaccines to eligible patients. Additionally, Merck supports healthcare professionals with resources like Merck Connect and Merck Manuals, distinguishing itself from competitors by its comprehensive support for both patients and healthcare providers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kenilworth, Illinois

Founded

1891

Simplify Jobs

Simplify's Take

What believers are saying

  • Positive Phase 3 results for pembrolizumab suggest new cancer treatment opportunities.
  • Kinase inhibitors' use in autoimmune diseases offers Merck portfolio diversification.
  • Merck's digital health innovation leadership strengthens its competitive position.

What critics are saying

  • Data privacy concerns may arise from AI integration in healthcare settings.
  • Oral peptide delivery faces scientific and regulatory challenges.
  • Intensifying competition from companies like Novartis may impact Merck's market share.

What makes Merck unique

  • Merck's collaboration with Microsoft enhances clinical workflows using AI in healthcare.
  • The Cyprumed deal aims to make peptide drugs orally available, improving patient experience.
  • Merck's investment in vaccine manufacturing aligns with rising global vaccine demand.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Holidays

Paid Vacation

Paid Sick Leave

Hybrid Work Options

Flexible Work Hours

Company News

Healthcare Dive
Apr 16th, 2025
Merck Manuals Integrates Medical Reference Within Microsoft Copilot Studio

This collaboration exemplifies a commitment to enhancing clinical workflows by incorporating Merck Manuals' authoritative content into Microsoft's healthcare agent service in Copilot Studio.

Sandra Gona
Apr 16th, 2025
India logs 2,430 new Covid cases_Spider information

As a result of these efforts, Merck has been recognized as a "Digital Health Innovation Leader" for two consecutive years since 2023.

BioSpace
Apr 15th, 2025
Merck Eyes Oral Peptide Delivery With Cyprumed Deal Worth up to $493M

Merck on Tuesday entered into a nonexclusive licensing and option pact with Austrian biotech Cyprumed in a bid to make its peptide drugs orally available.

PR Newswire
Apr 14th, 2025
Merck Manuals To Collaborate With Microsoft To Integrate Medical Information Resources Into Healthcare Agent Service In Microsoft Copilot Studio

RAHWAY, N.J., April 14, 2025 /PRNewswire/ -- The Merck Manuals is pleased to announce its collaboration with Microsoft to integrate its esteemed professional medical reference into healthcare agent service in Microsoft Copilot Studio. This exciting initiative harnesses the power of Generative AI (GenAI) to provide clinicians with trusted, comprehensive, and evidence-based medical content at the point of care.The Merck Manuals is proud to be an independent (non-government) medical information resource integrated into this platform. This collaboration exemplifies a commitment to enhancing clinical workflows by incorporating Merck Manuals' authoritative content into Microsoft's healthcare agent service in Copilot Studio. This integration empowers healthcare technology developers to create generative AI-driven healthcare agents that leverage this high-value content to grant clinicians immediate access to vital medical information."Clinicians and healthcare organizations worldwide depend on the Merck Manuals and MSD Manuals for accurate and reliable answers to their clinical questions," stated Dr. Sandy Falk, Editor-in-Chief of the Merck Manuals. "Through this collaboration with Microsoft, we are building solutions to deliver our comprehensive, evidence-based content to meet the needs of healthcare professionals

APP
Apr 14th, 2025
Novartis plans $23B expansion of manufacturing in US, including North Jersey site

Merck announced plans to spend $1 billion on a vaccine manufacturing site in North Carolina, plus $8 billion on other upgrades.